• Users Online: 68
  • Print this page
  • Email this page
CASE REPORT
Year : 2021  |  Volume : 1  |  Issue : 1  |  Page : 123-126

Active concurrent central serous chorioretinopathy and pachychoroid neovasculopathy managed with combination therapy of photodynamic therapy and anti-vascular endothelial growth factor agent


Department of Vitreo Retina, Aditya Birla Sankara Nethralaya, Mukundapur, Kolkata, West Bengal, India

Correspondence Address:
Dr. Rupak Roy
Aditya Birla Sankara Nethralaya, 147, Mukundapur, E.M. Bypass, Kolkata - 700 099, West Bengal
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijo.IJO_836_20

Rights and Permissions

Pachychoroid disease spectrum includes central serous chorioretinopathy (CSR) and pachychoroid neovasculopathy (PNV). Pachychoroid phenotype is characterized by choroidal hyperpermeability, dilated choroidal vessels (pachyvessels), and focal or diffuse increase in choroidal thickness. Newer imaging modalities have aided in the diagnosis of choroidal diseases. Herein, we present a case of active concurrent CSR with PNV in a middle-aged patient with successful treatment by photodynamic therapy and intravitreal anti-vascular endothelial growth factor (VEGF) (ranibizumab) injection.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed406    
    Printed8    
    Emailed0    
    PDF Downloaded21    
    Comments [Add]    

Recommend this journal